Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.47 USD | -1.69% |
|
+4.89% | +55.13% |
24/06 | Enliven Therapeutics, Inc.(NasdaqGS:ELVN) added to S&P Pharmaceuticals Select Industry Index | CI |
11/06 | Baird Initiates Enliven Therapeutics With Outperform Rating, $32 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+55.13% | 100.99Cr | |
+16.45% | 12TCr | |
+21.96% | 12TCr | |
+25.53% | 2.7TCr | |
-20.05% | 2.04TCr | |
-16.28% | 1.59TCr | |
-15.73% | 1.64TCr | |
-44.35% | 1.56TCr | |
+63.91% | 1.49TCr | |
+2.52% | 1.36TCr |
- Stock Market
- Equities
- ELVN Stock
- News Enliven Therapeutics, Inc.
- Enliven Therapeutics Q1 Loss Narrows